Literature DB >> 24365472

The novel isoxazoline ectoparasiticide fluralaner: selective inhibition of arthropod γ-aminobutyric acid- and L-glutamate-gated chloride channels and insecticidal/acaricidal activity.

Michael Gassel1, Christian Wolf1, Sandra Noack1, Heike Williams1, Thomas Ilg2.   

Abstract

Isoxazolines are a novel class of parasiticides that are potent inhibitors of γ-aminobutyric acid (GABA)-gated chloride channels (GABACls) and L-glutamate-gated chloride channels (GluCls). In this study, the effects of the isoxazoline drug fluralaner on insect and acarid GABACl (RDL) and GluCl and its parasiticidal potency were investigated. We report the identification and cDNA cloning of Rhipicephalus (R.) microplus RDL and GluCl genes, and their functional expression in Xenopus laevis oocytes. The generation of six clonal HEK293 cell lines expressing Rhipicephalus microplus RDL and GluCl, Ctenocephalides felis RDL-A285 and RDL-S285, as well as Drosophila melanogaster RDLCl-A302 and RDL-S302, combined with the development of a membrane potential fluorescence dye assay allowed the comparison of ion channel inhibition by fluralaner with that of established insecticides addressing RDL and GluCl as targets. In these assays fluralaner was several orders of magnitude more potent than picrotoxinin and dieldrin, and performed 5-236 fold better than fipronil on the arthropod RDLs, while a rat GABACl remained unaffected. Comparative studies showed that R. microplus RDL is 52-fold more sensitive than R. microplus GluCl to fluralaner inhibition, confirming that the GABA-gated chloride channel is the primary target of this new parasiticide. In agreement with the superior RDL on-target activity, fluralaner outperformed dieldrin and fipronil in insecticidal screens on cat fleas (Ctenocephalides felis), yellow fever mosquito larvae (Aedes aegypti) and sheep blowfly larvae (Lucilia cuprina), as well as in acaricidal screens on cattle tick (R. microplus) adult females, brown dog tick (Rhipicephalus sanguineus) adult females and Ornithodoros moubata nymphs. These findings highlight the potential of fluralaner as a novel ectoparasiticide.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cat flea; Cattle tick; Ectoparasiticidal target; Fipronil; Fluralaner; GABA-gated chloride channel; Glutamate-gated chloride channel; Isoxazoline

Mesh:

Substances:

Year:  2013        PMID: 24365472     DOI: 10.1016/j.ibmb.2013.11.009

Source DB:  PubMed          Journal:  Insect Biochem Mol Biol        ISSN: 0965-1748            Impact factor:   4.714


  60 in total

1.  Evidence for Personal Protective Measures to Reduce Human Contact With Blacklegged Ticks and for Environmentally Based Control Methods to Suppress Host-Seeking Blacklegged Ticks and Reduce Infection with Lyme Disease Spirochetes in Tick Vectors and Rodent Reservoirs.

Authors:  Lars Eisen; Marc C Dolan
Journal:  J Med Entomol       Date:  2016-09-01       Impact factor: 2.278

2.  Study on the effect of an ion channel inhibitor "Fluralaner" on Echinococcus granulosus protoscolices and metacestode layers in vitro.

Authors:  Fatima Zahran; Hayam Mohamed Ezz El-Din; Mai Abdel Sameaa Shehata
Journal:  J Parasit Dis       Date:  2020-04-24

3.  Gold redox catalysis for cyclization/arylation of allylic oximes: synthesis of isoxazoline derivatives.

Authors:  Abiola Azeez Jimoh; Seyedmorteza Hosseyni; Xiaohan Ye; Lukasz Wojtas; Yong Hu; Xiaodong Shi
Journal:  Chem Commun (Camb)       Date:  2019-07-09       Impact factor: 6.222

4.  Efficacy of afoxolaner plus milbemycin oxime and afoxolaner alone as treatment for sarcoptic mange in naturally infested dogs.

Authors:  Camilo Romero-Núñez; Linda G Bautista-Gómez; Galia Sheinberg; Alberto Martín-Cordero; Ariadna Flores-Ortega; Rafael Heredia-Cárdenas
Journal:  Can J Vet Res       Date:  2020-07       Impact factor: 1.310

5.  Efficacy of combination products containing sarolaner, moxidectin and pyrantel (Simparica Trio™) or afoxolaner and milbemycin (NexGard Spectra®) against induced infestations of Ixodes holocyclus in dogs.

Authors:  Raj Packianathan; Andrew Hodge; Natalie Bruellke; Chrissie Jackson; Steven Maeder
Journal:  Parasit Vectors       Date:  2020-09-05       Impact factor: 3.876

6.  Repurposing isoxazoline veterinary drugs for control of vector-borne human diseases.

Authors:  Marie Miglianico; Maarten Eldering; Hannah Slater; Neil Ferguson; Pauline Ambrose; Rosemary S Lees; Karin M J Koolen; Katerina Pruzinova; Magdalena Jancarova; Petr Volf; Constantianus J M Koenraadt; Hans-Peter Duerr; Graham Trevitt; Baiyuan Yang; Arnab K Chatterjee; John Wisler; Angelika Sturm; Teun Bousema; Robert W Sauerwein; Peter G Schultz; Matthew S Tremblay; Koen J Dechering
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-02       Impact factor: 11.205

7.  Fluralaner activity against life stages of ticks using Rhipicephalus sanguineus and Ornithodoros moubata IN in vitro contact and feeding assays.

Authors:  Heike Williams; Hartmut Zoller; Rainer K A Roepke; Eva Zschiesche; Anja R Heckeroth
Journal:  Parasit Vectors       Date:  2015-02-08       Impact factor: 3.876

8.  A quantitative evaluation of the extent of fluralaner uptake by ticks (Ixodes ricinus, Ixodes scapularis) in fluralaner (Bravecto) treated vs. untreated dogs using the parameters tick weight and coxal index.

Authors:  Heike Williams; Janina Demeler; Janina Taenzler; Rainer K A Roepke; Eva Zschiesche; Anja R Heckeroth
Journal:  Parasit Vectors       Date:  2015-06-30       Impact factor: 3.876

9.  A novel combination of fipronil and permethrin (Frontline Tri-Act®/Frontect®) reduces risk of transmission of Babesia canis by Dermacentor reticulatus and of Ehrlichia canis by Rhipicephalus sanguineus ticks to dogs.

Authors:  Frans Jongejan; Christa de Vos; Josephus J Fourie; Frederic Beugnet
Journal:  Parasit Vectors       Date:  2015-11-19       Impact factor: 3.876

10.  A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of Bravecto (fluralaner) against Frontline (fipronil) in flea- and tick-infested dogs.

Authors:  Nadja Rohdich; Rainer K A Roepke; Eva Zschiesche
Journal:  Parasit Vectors       Date:  2014-03-04       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.